4 ANTI-VEGF/DLL4 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
다가이고 다중 특이적인 결합 단백질, 상기 결합 단백질의 제조 방법, 및 이상 DLL4 및/또는 VEGF 발현 또는 활성을 특징으로 하는, 암, 종양, 및/또는 다른 혈관신생-의존적 질환의 진단, 모니터링, 억제, 예방 및/또는 치료시의 상기 결합 단백질의 용도가 본원에 개시된다. Disclosed herein are multivalent and multispecific binding proteins, methods of making the binding proteins, and their uses in the diagnosis,...
Saved in:
Main Authors | , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
19.08.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 다가이고 다중 특이적인 결합 단백질, 상기 결합 단백질의 제조 방법, 및 이상 DLL4 및/또는 VEGF 발현 또는 활성을 특징으로 하는, 암, 종양, 및/또는 다른 혈관신생-의존적 질환의 진단, 모니터링, 억제, 예방 및/또는 치료시의 상기 결합 단백질의 용도가 본원에 개시된다.
Disclosed herein are multivalent and multispecific binding proteins, methods of making the binding proteins, and their uses in the diagnosis, monitoring, inhibition, prevention and/or treatment of cancers, tumors, and/or other angiogenesis-dependent diseases diseases characterized by aberrant DLL4 and/or VEGF expression or activity. |
---|---|
AbstractList | 다가이고 다중 특이적인 결합 단백질, 상기 결합 단백질의 제조 방법, 및 이상 DLL4 및/또는 VEGF 발현 또는 활성을 특징으로 하는, 암, 종양, 및/또는 다른 혈관신생-의존적 질환의 진단, 모니터링, 억제, 예방 및/또는 치료시의 상기 결합 단백질의 용도가 본원에 개시된다.
Disclosed herein are multivalent and multispecific binding proteins, methods of making the binding proteins, and their uses in the diagnosis, monitoring, inhibition, prevention and/or treatment of cancers, tumors, and/or other angiogenesis-dependent diseases diseases characterized by aberrant DLL4 and/or VEGF expression or activity. |
Author | HICKSON JONATHAN A GU JIJIE HAASCH DEANNA L CHARI RAVI GUPTA SUPRIYA CAO XIANHUA LAPPE SUSAN E AMBROSI DOMINIC J ZAMIRI CAMELLIA NAUMOVSKI LOUIE LI YINGCHUN |
Author_xml | – fullname: HAASCH DEANNA L – fullname: LAPPE SUSAN E – fullname: CHARI RAVI – fullname: LI YINGCHUN – fullname: AMBROSI DOMINIC J – fullname: GU JIJIE – fullname: NAUMOVSKI LOUIE – fullname: GUPTA SUPRIYA – fullname: CAO XIANHUA – fullname: HICKSON JONATHAN A – fullname: ZAMIRI CAMELLIA |
BookMark | eNrjYmDJy89L5WRwM1Fw9Avx1A1zdXfTd_HxMVFwCXX0UQhzDPJ0dPJxVXDx93X09FPw9PUN9fN39_F3CvXx9AsG6nFRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgaGlgYGlmYmppaOxsSpAgBFIC6d |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | 항-VEGF/DLL4 이원 가변 도메인 면역글로불린 및 이의 용도 |
ExternalDocumentID | KR20190096459A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_KR20190096459A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:28:37 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_KR20190096459A3 |
Notes | Application Number: KR20197023545 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190819&DB=EPODOC&CC=KR&NR=20190096459A |
ParticipantIDs | epo_espacenet_KR20190096459A |
PublicationCentury | 2000 |
PublicationDate | 20190819 |
PublicationDateYYYYMMDD | 2019-08-19 |
PublicationDate_xml | – month: 08 year: 2019 text: 20190819 day: 19 |
PublicationDecade | 2010 |
PublicationYear | 2019 |
RelatedCompanies | ABBVIE INC |
RelatedCompanies_xml | – name: ABBVIE INC |
Score | 3.2004502 |
Snippet | 다가이고 다중 특이적인 결합 단백질, 상기 결합 단백질의 제조 방법, 및 이상 DLL4 및/또는 VEGF 발현 또는 활성을 특징으로 하는, 암, 종양, 및/또는 다른 혈관신생-의존적 질환의 진단, 모니터링, 억제, 예방 및/또는 치료시의 상기 결합 단백질의 용도가 본원에 개시된다.... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | 4 ANTI-VEGF/DLL4 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190819&DB=EPODOC&locale=&CC=KR&NR=20190096459A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8IJo1DdFjR9ommj2thBgHfSBmG3tYLIPsmyEN7LNLjEaIDLj3_c2QXnire2ll-sl99neFeCpKxOW5CnD2CTTVU1P22o_lX21Kzs6e9XzdpKWqQHP10ex9jKjsxp8bGthqj6h31VzRJSoDOW9qPT16j-Jxau3letW-oZLy2c7GnBlEx2jdUMLp3BzICYBDyzFsgbjUPHDXxi66xplxgEclo502WlfTM2yLmW1a1TsMziaIL5FcQ6192UDTqzt32sNOPY2V9443Ejf-gJsjRh-5KhTMbRb3HU1wmPDJVMjdAzTFYQHnuH4xPG82A-GbmDGLsbmuIeTGNUmiUYiFIF9CY-2iKyRigTN_84_H4e71HevoL5YLuQ1kEwmOdVSSjMMemiSMcokRS5nTPZ6UnZuoLkP0-1-8B2cltMygdpmTagXn1_yHi1wkT5UjPsBUuSDhA |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUeMHahPN3hYCWwd9IGZbNzbZB1k2whvZZkmMBojM-O97m6A88db00sv1krvr79q7AjwpImXpPGOITXJNVrWsI_cz0ZcV0dXYqzbvpFmZGvADzUnUlymd1uBjWwtT9Qn9rpojokXlaO9F5a9X_0ksXr2tXLezN5xaPtvxgEsbdIzRDSOcxI2BNQ55aEqmORhFUhD90vC4rlKmH8BhD0Fh2WnfmhhlXcpqN6jYp3A0Rn6L4gxq78smNMzt32tNOPY3V9443Fjf-hxslehB7MoTa2i3ueephCe6RyZ65OqGZxEe-robENf3kyAceqGReIjNcQ0nCbpNEjtWZIX2BTzaVmw6Mgo0-9v_bBTtSq9cQn2xXIgrILlI51TNKM0R9NA0Z5QJilrOmej1hOheQ2sfp5v95AdoOLHvzVDU0S2clKQymdphLagXn1_iDqNxkd1XSvwBnu6Gbw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=4+ANTI-VEGF%2FDLL4+DUAL+VARIABLE+DOMAIN+IMMUNOGLOBULINS+AND+USES+THEREOF&rft.inventor=HAASCH+DEANNA+L&rft.inventor=LAPPE+SUSAN+E&rft.inventor=CHARI+RAVI&rft.inventor=LI+YINGCHUN&rft.inventor=AMBROSI+DOMINIC+J&rft.inventor=GU+JIJIE&rft.inventor=NAUMOVSKI+LOUIE&rft.inventor=GUPTA+SUPRIYA&rft.inventor=CAO+XIANHUA&rft.inventor=HICKSON+JONATHAN+A&rft.inventor=ZAMIRI+CAMELLIA&rft.date=2019-08-19&rft.externalDBID=A&rft.externalDocID=KR20190096459A |